Vir Biotechnology's market cap is currently $730.70M. The company's EPS TTM is $-0.8; its P/E ratio is ―; Vir Biotechnology is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
